Search

List Grid

221 - 230 of 983 Results

  • Americans’ Attitudes and Experiences with COVID-19 Vaccines: What We’ve Learned from the Vaccine Monitor

    Event Date:
    Event

    Since before the first COVID-19 vaccine became available more than a year ago, the KFF COVID-19 Vaccine Monitor Project has tracked the public’s evolving views about and experiences with the vaccines amid the ongoing pandemic. On Feb. 8, 2022 KFF held a web briefing to share insights gleaned from nearly 40 Vaccine Monitor reports based on survey interviews with more than 24,000 people since December 2020.

  • Potential Health Policy Administrative Actions in the Second Trump Administration

    Tracker

    Potential health policy administrative actions under the incoming Trump administration based on campaign positions and statements by President-elect Trump, President Trump’s record during his first administration, and expected actions that would reverse or modify regulations or guidance issued by the Biden administration

  • Dave A. Chokshi Joins KFF Board of Trustees

    News Release

    San Francisco – KFF announced today that Dr. Dave Ashok Chokshi, a practicing physician and health leader, has joined KFF’s Board of Trustees.  Dr. Chokshi is a physician at Bellevue Hospital as well as Sternberg Family Professor of Leadership at the City College of New York. From 2020 to 2022, he served as the 43rd Health Commissioner of New York City, where he led the city’s response to the COVID-19 pandemic, including its historic campaign…

  • KFF COVID-19 Vaccine Monitor: January 2022

    Poll Finding

    This report shows that 42% of all adults have received a COVID-19 booster, including about 70% of those who are likely booster-eligible. More than three quarters (77%) have received at least one dose of a COVID-19 vaccine. The poll also explores the public's experiences getting at-home and in-person COVID-19 tests and other issues.

  • Mixed Prospects for Vaccinating Children

    From Drew Altman

    In this Axios column, Drew Altman examines the data about what parents say they will do once their children ages 5-11 become eligible for a COVID-19 vaccine, and why it will take some time and a concerted outreach effort to match adult vaccination rates.